Entrada Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TRDA)

Historical Holders from Q4 2021 to Q1 2025

Symbol
TRDA on Nasdaq
CUSIP
29384C108
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
37.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
30.6M
Holdings value
$529M
% of all portfolios
0.008%
Grand Portfolio weight change
+0%
Number of holders
101
Number of buys
58
Number of sells
-38
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Entrada Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TRDA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ROCHE FINANCE LTD 6.9% $23.2M 2.57M Roche Finance Ltd Dec 31, 2024
JANUS HENDERSON GROUP PLC 5.6% $18.8M 2.08M JANUS HENDERSON GROUP PLC Dec 31, 2024
BlackRock, Inc. 5.3% $17.8M 1.97M BlackRock, Inc. Dec 31, 2024

Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TRDA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 49.7K $449K -$621K $9.04 5
2024 Q4 30.6M $529M +$9.73M $17.29 101
2024 Q3 30.1M $481M +$6.08M $15.98 98
2024 Q2 29.7M $423M +$52.1M $14.25 82
2024 Q1 26M $369M -$4.35M $14.17 76
2023 Q4 26.3M $397M +$3.02M $15.09 61
2023 Q3 26M $411M +$4.52M $15.80 55
2023 Q2 25.8M $390M +$13.5M $15.14 56
2023 Q1 24.9M $361M +$2.52M $14.50 53
2022 Q4 24.7M $334M +$2.43M $13.52 46
2022 Q3 24.5M $386M -$2.72M $15.76 32
2022 Q2 24.8M $302M -$13M $12.18 32
2022 Q1 25.8M $243M +$2.25M $9.39 46
2021 Q4 25.4M $434M +$422M $17.12 46